Interaksi Klobazam dan Risperidon

Klobazam dan Risperidon: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Klobazam (SYMPAZAN) · berlaku sejak 2025-12-01

Mayor

Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Risk may be increased with concomitant use of other CNS depressants ( 5.4 , 5.5 )

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants Since SYMPAZAN ® has a central nervous system (CNS) depressant effect, patients or their caregivers should be cautioned against simultaneous use with other CNS depressant drugs or alcohol, and cautioned that the effects of other CNS depressant drugs or alcohol may be potentiated…

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Prescribers should monitor patients for somnolence and sedation, particularly with concomitant use of other central nervous system depressants.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

CNS Depressants and Alcohol Concomitant use of SYMPAZAN ® with other CNS depressants may increase the risk of sedation and somnolence [see Warnings and Precautions (5.4) ].

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Dari label Risperidon (RISPERDAL CONSTA) · berlaku sejak 2025-11-05

Moderat

Carbamazepine and other enzyme inducers decrease plasma concentrations of risperidone.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Fluoxetine and Paroxetine Fluoxetine (20 mg once daily) and paroxetine (20 mg once daily), CYP 2D6 inhibitors, have been shown to increase the plasma concentration of risperidone 2.5–2.8 fold and 3–9 fold respectively.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Carbamazepine and Other CYP 3A4 Enzyme Inducers Carbamazepine co-administration with oral RISPERDAL decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Co-administration of other known CYP 3A4 enzyme inducers (e.g., phenytoin, rifampin, and phenobarbital) with risperidone may cause similar decreases in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone, which could lead to decreased efficacy of RISPERDAL CONSTA treatment.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

At the initiation of therapy with carbamazepine or other known hepatic enzyme inducers, patients should be closely monitored during the first 4–8 weeks, since the dose of RISPERDAL CONSTA may need to be adjusted.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.